Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-08

Clinical Trial Update: Indolent Non Follicular Lymphomas Prognostic Project

View source ↗

Summary

The clinical trial NCT02904577 focusing on prognostic factors for indolent non-Hodgkin lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Fondazione Italiana Linfomi - ETS | Conditions: Indolent B-Cell Lymphomas | Status: COMPLETED